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Clinical Psychology

Detecting Simulated Cognitive Impairment with MMPI-2 Neurocorrection Scales.
Chairperson: Stuart Hall, PhD.

This study provides the first evidence that special neurocorrection scales of the second
edition o f the Minnesota Multiphasic Personality Inventory (MMPI-2; Butcher, Graham,
Tellegan, & Kaemmer, 1989) are superior to the Fake Bad Scale (FBS; Lees-Haley, Dunn,
& English, 1991) at differentiating traumatic brain injury (TBI) simulators compared to
controls. Two groups of undergraduate psychology students were assigned to either a TBI
simulator (n = 15) or control group (n = 17). Simulators were instructed to answer the
MMPI-2 items within the context of simulating late effects of a mild-to-moderate head
injury while pursuing financial compensation through litigation. A sample of community
TBI patients (n = 22) was used as a comparison group. Results indicated that the Alfano et
al. (1993) neurocorrection scale was clinically sensitive to TBI simulation ( d - 3.3), and
superior to the FBS (d = 1.8) compared to student controls. The Alfano scale achieved a
sensitivity rate of 86.7% compared to 73.3% for the FBS. Specificity for the Alfano scale
was 94.1% for an overall hit rate of 90.6%. The FBS achieved a specificity rate of 82.4%
with a total hit rate o f 78.1%. The neurocorrection scales were not effective at
differentiating TBI simulators from community TBI patients. Limitations include small
sample size and significant age differences between simulators and community TBI
patients. The sample was skewed toward females (66%) and Caucasians (95%). Future
studies should consider applying the neurocorrection scales in known-group studies
investigating TBI simulation. The validity of MMPI-2 results in neuropsychological
contexts is discussed.
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1
Detecting Simulated Cognitive Impairment with MMPI-2 Neurocorrection Scales

Introduction

Traumatic brain injury (TBI) is responsible for more deaths and disability than
any other neurological condition for individuals under age 50 (Center for Disease
Control, 2004). The United States reports between 1.5 and 3 million new cases of TBI
annually and up to 75% are classified as "mild" in severity. In spite of this fact, there are
still 50,000 deaths each year, with 5.3 million Americans estimated to be living with a
traumatic brain injury. This accounts for an annual figure of approximately 80,000
Americans experiencing long-term disability related to head trauma.
Clinical neuropsychologists are often called upon to evaluate the degree of
cognitive impairment secondary to TBI. Many assessment devices, including self-report
inventories, are often very useful in understanding a variety of psychosocial variables
associated with cognitive complaints after a head injury. However, these instruments are
not without certain vulnerabilities. For instance, self-report inventories of personality
functioning are particularly susceptible to many types of deceptive responding. Attorneys
have also been known to “coach” clients on how to respond to psychological inventories
(Youngjohn, 1995).
It has been reported that complaints related to TBI are the most common
neurological syndrome feigned (Haines & Norris, 1995). Consequently, base rates for
malingering vary considerably in forensic contexts and have been reported to occur at
rates up to 40% (Binder & Rohling, 1991; Fox, Lees-Haley, Earnest, & Dolezal-Wood,
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1995; Lees-Haley, Willis, & Brown, 1993; Mittenberg, Patton, Canyock, & Condit,
2002), and 10 times the base rate of bona fide cognitive impairment (Larrabee, 2000).
These data have prompted clinicians in the field of forensic neuropsychology to
incorporate measures of effort into their assessments as a standard of practice (Bender &
Rogers, 2004; Bush et al., 2005; Iverson & Binder, 2000; Slick, Sherman, & Iverson,
1999).
Nichols and Greene (1997) describe “simulation” as one end of a continuum (i.e.
ranging from simulation to dissimulation) where simulation refers to masking coping
resources and simulating a greater degree of impairment than an individual may actually
be experiencing and dissimulation is where individuals mask impairment in hopes of
presenting a favorable impression (p. 255). The evaluation of malingering and symptom
exaggeration poses numerous problems for clinicians. Many have resorted to examining
constructs that are believed to be directly associated with malingering as well as
discrepancies in assessment information. One of these constructs is the amount o f effort
one utilizes during the evaluation.
Effort has been defined as the “investment in performing at capacity levels” on a
given effort based test (Bush, et al., 2005, p. 420). Inferences about performance are
conceptualized along continuums of effort and honesty in which these two constructs
may vary given the setting and circumstances of examination. Additional continua
include intention, or volition, and incentive. The intention continuum ranges from
conscious, volitional control over the decision to simulate impairment, as in malingering,
to an unconscious, or unawareness that one is producing the symptoms, such as in
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conversion disorder (Slick, et al., 1999). Regarding incentives or rewards, the range is
from internal or psychological incentive to an external reward such as financial
compensation or avoidance o f responsibility.
Slick et al. (1999) present criteria for diagnosing the malingering of
neurocognitive dysfunction based on a variety of pieces of converging evidence. These
include the presence of a substantial external incentive, negative response bias or failure
on measures of effort, discrepancies between test data and behavior, inconsistencies
between test data and reliable collateral reports, and inconsistencies between a person’s
historical information and test data. Additional considerations for diagnosing malingering
include differences in cultural background, differential diagnoses, premorbid behavior,
and the psychometric properties o f tests used in the evaluation (Slick, et al., 1999).
Considering recent evidence that suggests that effort accounts for over half of the
overall variance in neuropsychological test batteries (Green, Rohling, Lees-Haley, &
Allen, 2001), it is prudent for psychologists to incorporate measures of effort in their
examinations. The current study focuses on one approach that may improve the ability to
make accurate judgments about score validity using the second edition of the Minnesota
Multiphasic Personality Inventory (MMPI-2; Butcher, Dahlstrom, Graham, Tellegan, &
Kaemmer, 1989).
The MMPI-2 and its predecessor, the MMPI (Hathaway & McKinley, 1943), have
been the most common personality instruments used by clinical neuropsychologists in the
United States for a number o f years (Camara, Nathan, & Puente, 2000; Lees-Haley, 1992;
Lubin, Larsen, & Matarazzo, 1984; Rabin, Barr, & Burton, 2005). The MMPI-2 is
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routinely utilized as a measure of psychopathology and personal adjustment in both
clinical and neuropsychological evaluations and can provide useful information regarding
the degree o f distress and symptoms one is experiencing from a variety of neurological
conditions (Lezak, Howieson, & Loring, 2004; Reitan & Wolfson, 1993).
The MMPI-2 is also often integrated into forensic and neuropsychological
evaluations for its well established validity scales that measure exaggeration of
psychiatric symptoms (Berry, Baer, & Harris, 1991; Graham, Watts, & Timbrook, 1991;
Rogers, Sewell, & Salekin, 1994). Lees-Haley, English, and Green (1991) developed the
Fake Bad Scale (FBS) and subsequently validated its use for detecting emotional and
somatic exaggeration in personal injury evaluations (Larrabee, 1998). Recent research
also claims that the FBS is a useful measure for detecting exaggeration of cognitive
complaints associated with head injury (Larrabee, 2003; Martens, Donders, & Millis,
2001; Ross, Millis, Krukowski, Putnam, & Adams, 2004). This study hypothesizes that
there may be a superior alternative to the FBS when the primary complaints are related to
cognitive impairment.
There have been a series of studies that have developed special neurological
scales from MMPI-2 items that have demonstrated sensitivity to detecting individuals
with brain injury (Alfano, et al., 1993; Artzy, 1996; Gass, 1991; Gass & Russell, 1991;
Van Balen, et al., 1997). We propose that these special neurocorrection scales contain
item content that simulators of traumatic brain injury are more likely to endorse. In
addition, it is believed that the neurocorrection scales are more sensitive to TBI
simulation than the Fake Bad Scale.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

5
Neurological Scale Development with the MMPI
The first neurological scale for the MMPI was the Caudality (Ca) scale (Williams,
1952). The Ca scale contained 37 items and successfully differentiated patients with
frontal lesions from patients with parietal lesions. Differences in response profiles
indicated that individuals with frontal lesions were characterized by “inhibition, low
aspiration, and peculiar thought processes,” where as patients with parietal lesions
exhibited “introversion, anxiety, and depression” (p. 296).
Creating and applying special neurological scales to identify personality changes
associated with cognitive impairment became a major focus of research in the years
following (Meier, 1969). Several researchers developed scales that were designed to
distinguish between neurological and schizophrenic groups, with follow-up and
validation studies demonstrating minimal clinical utility (Hovey, 1964; Horton, 1983;
Horton & Wilson, 1981; Meier & French, 1964; Sand, 1973; Shaw & Mathews, 1973;
Siskind, 1976; Upper & Seeman, 1968).
Item Bias and Symptom Nonspecificity
In a study which would have substantial impact on how the MMPI was
interpreted, Ayers, Templar, and Ruff (1975) demonstrated that a scale devised to
differentiate schizophrenic men from those with brain damage faired no better than scale
8 - Schizophrenia in doing so. In a follow-up study, they validated their conclusions by
reporting that the special neurological scales were related more to indices of
psychopathology rather than indices of brain damage. In fact, they raised the contention
that the special scales were biased toward psychopathology in general and schizophrenia
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specifically (Ruff, Ayers, & Templar, 1977). The study also demonstrated that items
could be endorsed by diagnostically separate groups, including neurological and
psychiatric groups with similar symptomatology. When this happens, clinicians
interpreting the MMPI in the standard fashion can inadvertently equate elevated MMPI
scales with psychopathology instead o f neurological sequelae.
Previous studies have produced equivocal results linking MMPI variables to
neuropsychological variables (Cripe, 1996). For instance, several studies have indicated
that the MMPI is insufficient at determining degrees of psychopathology for lateralized
brain injuries and language disturbances (Dikmen & Reitan, 1974a; Dikmen & Reitan,
1974b; Moehle & Fitzhugh-Bell, 1988). Similarly, another study found that the MMPI
was unable to detect post-operative changes in temporalobectomy patients regardless of
side of onset (Trenerry, et al., 1996). Highlighting this trend, another study demonstrated
that measures of personality and measures of neuropsychological constructs may create
an artificial distinction due to the method variance contained in the MMPI. In other
words, the reason that the MMPI appears to have an orthogonal, or distinctive structure,
was based on the method of taking the test and not because an actual, statistical
difference exists between tests of cognition and tests of personality (Zillmer & Perry,
1996).
This began to illuminate the inherent problem that individuals may endorse items
on the MMPI-2 representative of cognitive impairment instead of psychopathology
(Reitan & Wolfson, 1997; Tate, 1999). Bomstein and Kozora (1990) demonstrated that
the MMPI-2 items were nonspecific to psychiatric or neurological content. In their study,
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scale 8 was unable to differentiate patients diagnosed with epilepsy from patients
diagnosed with schizophrenia. Their research amplified once again the inherent problem
o f item nonspecificity that Ayers and colleagues discussed. However, others have found
evidence that the MMPI is useful in neuropsychological evaluations (Gass, 1991b;
Larrabee, 2003).
Subsequent studies aimed at associating MMPI variables with neuropsychological
test variables revealed that the MMPI does contain item content reflective of
neuropsychological domains. In a series of studies research demonstrated that cognitive
variables such as attention, memory, speech impairment, information processing speed,
and cognitive efficiency are associated with certain MMPI elevations (Gass, 1991; Gass,
1996; Ross, Putnam, Gass, Bailey, & Adams, 2003). Some suggested that, if interpreted
correctly, the MMPI could offer useful information in the neuropsychological context
(Gass, 1991b). Researchers continued to pursue approaches that might improve the
validity of the MMPI in neurological populations. Unlike prior research that focused on
scale development or decision rules (Russell, 1975; Watson & Thomas, 1968), some
researchers devised procedures for altering the actual profile by eliminating items from
the Clinical scales that contain “neurologically related” content (Gass & Russell, 1991).
Correcting the MMPI-2 fo r TBI Symptoms
The understanding that items on the MMPI could reflect both neurological and
psychiatric symptoms led to questioning the appropriateness of the MMPI / MMPI-2 in
neuropsychological examinations (Cripe, 1996). One approach that attempted to address
this issue is described as “neurocorrection.” Neurocorrection refers to the process of
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identifying items that contain neurological content and subsequently deleting those items
from their respective scales and then replotting the profile. The profile is then said to be
neurocorrected. Essentially, this method corrects for scale elevations in which items
could theoretically be endorsed due to neurological symptoms rather than symptoms of
psychopathology.
Gass and Russell (1991) conducted the first study of neurocorrecting the MMPI
with patients with head injury. MMPI prorated raw scores were applied to neurological
items that assigned a new value to the items that were “equivalent to the individual’s ratio
o f non-neurological item endorsement in each scale” (p. 255). By adjusting profiles with
a weighted score, the raw score can be interpreted in proportion to the original profile.
In a study that attempted to address the limitations of the first, Gass (1991) added
a control group and derived neurological items in an empirical manner. First, items were
selected that could reasonably be indicative of head injury. The researchers then gave the
370 item version MMPI to 75 patients diagnosed with various degrees of brain injury.
The researchers then derived through principal components analysis two factors. Factor
one consisted of 14 items that accounted for the main source of variance (24%). The
items reflect somatic and cognitive related content.
This correction of the scales attenuates or suppresses MMPI profiles in patients
with head injury. Gass (1991) explains that this deflation in the profile more accurately
reflects the individual's psychiatric status because the scales have been corrected for
neurological complaints. Interpreting the basic profile becomes more meaningful than the
attempts at using the instrument as a diagnostic tool. Other researchers have followed
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Gass’s original study and constructed their own neurocorrection scales by using both
rational and empirical methods. (Alfano, et al., 1993; Artzy, 1996; Van Balen, et al,
1997).
Brulot, Strauss, and Spellacy (1997) tested the validity of the empirical correction
scales related to injury severity, neuropsychological test performance, and depression.
The authors devised a hybrid scale in which at least two items overlapped from the Gass
(1991), Alfano et al. (1993), or Artzy (1996) correction scales. There were no
associations between the correction factors and injury severity as measured by loss of
consciousness (LOC and post-traumatic amnesia (PTA), and neuropsychological test
performance overall. In addition, the authors found that the correction factors did
significantly relate to the MMPI-2 content scale of depression (DEP), suggesting that
items on this scale may also contribute to content bias as observed in previous studies
with scale 8.
This finding led the authors to questions the validity o f the correction factors as
reflecting physical and cognitive impairments rather than emotional disturbances. Thus,
due to the moderate correlations between the DEP scale and the correction scales, the
nonspecificity of mild head injury symptoms and depression lead to problems in
differentiating the respective domains of impairment. As in the Edwards et al. (2003)
study, acute symptoms of TBI reflect more of the physical attributes of impairment, and
as symptoms persist, somatic and affective symptoms may dominate complaints.
However, as cognitive symptoms remit, so should symptoms reflecting emotional and
psychological maladjustment (Gualtiere, 1995).
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In an attempt to validate the neurobehavioral content o f Gass's (1991) correction
scale, Rayls, Mittenberg, Bums, and Theroux (2000) tested Gass’s neurological
correction scale in patients meeting criteria for mild head trauma. Their results indicated
that Gass’s items reflect acute mild head trauma sequelae, given that there were no
significant differences in item endorsement rates for the chronic profiles compared to the
normative group. As suggested by the authors, one possible explanation for their results
could be that endorsement o f neurologically related items is “related to depression rather
than cognitive impairment" (p. 549). They go on to add that test-takers may endorse
items by misattributing item content reflective of emotional maladjustment.
Edwards et al. (2003) administered the full MMPI-2 to a group of 35 patients with
differing levels of head injury severity. In addition to the head injury sample, a group of
35 psychiatric patients with no reported history o f organic brain syndrome or
neurological disorder were selected as a comparison group. The psychiatric group
consisted of patients diagnosed with a variety of affective disorders and substance abuse.
The authors compared three different correction scales, one of which was developed on
group of multiple sclerosis patients (Meyerink, Reitan, & Setz, 1988). Results indicated
that that none of the scales produced significant differences in rates of item
endorsements. In addition, profile changes led to clinically relevant information for
interpretive means. Yet the authors acknowledge that correction of the clinical scales may
lead to psychometrically new scales yet to be validated.
Glassmire et al. (2003) also tested the classification ability of the neurocorrection
scales from Gass (1991), Alfano et al. (1993), and Gass & Russell (1991). Like other
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studies, results indicated that the neurocorrection scales demonstrated good ability to
differentiate head injured patients from normals. However, they failed to demonstrate
adequate ability to differentiate TBI patients from psychiatric patients.
Studies examining the use of the MMPI-2 in neuropsychological contexts have
produced inconsistent results (Cripe, 1996). A large body of literature has identified
additional variables that may influence MMPI-2 scale profiles. These variables may
prolong cognitive impairment and maintain neuropsychological complaints.
Variables That Moderate MMPI-2 Profiles
Larrabee (1999) discusses several moderating variables that could influence the
degree o f symptom expression indicated on the MMPI-2 profile. Included are injury
variables such as length PTA, duration of LOC, or the emergence of post-traumatic
seizures. Persons with mild head injuries reflect a greater deficit or dysfunctional level on
the MMPI-2 clinical scales than those with more severe head injuries. This is referred to
as the “paradoxical severity effect” (Youngjohn, Burrows, & Erdal, 1995). The
phenomenon is amplified even more when individuals are involved in litigation (Binder
& Rohling, 1996; Hoffman, Scott, Emick, & Adams, 1999; Youngjohn, Davis, & Wolf,
1997). Other variables include subject variables such as age, adverse life events, chronic
social difficulties, gender, and symptom expression like somatization (Larrabee, 1999).
TBI Simulation and the MMPI-2 Fake Bad Scale
Historically, clinicians have attributed late effects o f mild head injury to
psychogenic factors or external incentives (Gasquoine, 1998; Strauss & Savitsky, 1934;
Tate, 1998,2003). In a recent survey of the National Academy of Neuropsychology and
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Division 40 of the American Psychological Association, it was reported that forensic
referrals make up the second highest reimbursement source in private practice clinical
neuropsychology (Sweet, Peck, Abramowitz, & Etzweiller, 2003). In addition, referrals
from attorneys represent the third highest referral source behind psychiatry and
neurology, respectively (Sweet, Moberg, & Suchy, 2000). It has been demonstrated
through meta-analyses that the MMPI-2 Validity and malingering scales are sensitive to
certain forms of psychopathology (Berry, Baer, & Harris, 1991; Graham, et al., 1991;
Rogers, 2003). However, the validity scales and special malingering scales are not
specific to head injury or malingering o f cognitive impairment (Greiffenstein, Gola, &
Baker, 1995; Lamb, Berry, Wetter, & Baer, 1994).
In order to address malingering in personal injury contexts, Lees-Haley, English,
and Glenn (1991) developed a scale specifically for the purpose of detecting exaggerated
emotional distress. Inspired by Gough's Dissimulation Scale (Ds; Gough, 1947) and
applied practically based on clinical experience, Lees-Haley and colleagues selected
items that represented both simulation and dissimulation characteristics. These include
not only the exaggeration of neurobehavioral symptoms, but also the concealment of
deviant behavior and presenting oneself in a positive manner. The result of their effort
was the creation o f the Fake Bad Scale and studies have reported the clinical utility of
detecting exaggeration of complaints related to TBI (Larrabee, 2003; Martens, Donders,
& Millis, 2001; Ross, Millis, Krukowski, Putnam, & Adams, 2004).
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The FBS consists of 43 items obtained from MMPI responses from personal
injury claimants who “appeared to be clearly malingering” (p. 205). The responses tended
to fit a model that reflected:
“ 1) appearing honest; 2) appearing psychologically normal except for the
influence of the alleged cause of injury; 3) avoiding admitting preexisting
psychopathology; 4) attempting to minimize the impact of previously disclosed
preexisting complaints; 5) minimizing or hiding perjury, antisocial or illegal
behavior; and 6) presenting a degree of injury or disability within perceived limits
of plausibility” (Lees-Haley, et al., 1991, p. 204).
Utilizing a cutoff point of 20 on the FBS for all groups, the scale classified 96% of the
malingering group, as opposed to the non-malingering claimants who were correctly
classified at the 90% level. A total accuracy rate of 93% for both groups filing claims was
obtained. For the medical outpatients simulating a motor vehicle accident, toxic exposure,
and job stress, the scale correctly classified 88%, 53%, and 83% respectively. It was clear
that the performance of the FBS initially looked promising for the purpose of detecting
simulated impairment during personal injury evaluations (Lees-Haley, Iverson, Lange,
Fox, & Allen, III, 2002). However, additional studies would call the construct validity of
the FBS into question, sparking a current debate questioning the utility of the FBS in
personal injury examinations (Butcher, Arbisi, Atlis, & McNulty, 2003; Rogers, 2003).
Concerned about the construct validity on the FBS, Butcher et al. (2003)
examined MMPI-2 archival files from 108,791 subjects compiled between 1990 and
1996. Six settings were represented in the analysis, and, when a conservative cutoff of 26
was applied, between 2.4 - 30% of the individuals were classified as malingering. The
authors concluded that the FBS over-predicts malingering despite adjusting cutoff scores
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for differences in setting base rates. Instead, Butcher et al. state that the FBS reflects a
broad variety o f somatic symptoms and is "associated more with the expression of
psychopathology in which physical symptoms are experienced" (p.482). Butcher and
colleagues subsequently called for the abandonment of the FBS for detecting somatic
malingering (Arbisi & Butcher, 2004).
Dearth et al. (2005) used an analog design in which they tested the ability of the
FBS to classify TBI simulators above and beyond that of the other validity scales
contained in the MMPI-2. Their results showed that the FBS was superior to the
traditional validity scales, suggesting a different “operating profile” than the standard F
family of validity scales, particularly in settings with high base rates of malingering head
injury.
However, there has only been one study that considered neurocorrection
procedures as a useful technique in differentiating MMPI profiles between patients
undergoing a forensic neuropsychological evaluation for head injuries and patients
involved in a forensic psychological evaluation. Dunn and Lees-Haley (1995) tested the
effectiveness of the Gass (1991) correction procedure in which 14 items were deleted
from the standard profile. Results demonstrated that the correction procedure did not
significantly differentiate persons litigating personal injury or primarily whiplash and
head injured group profiles. In fact, they reported that only 5 items were significantly
differentially endorsed by the two groups out of the total 14. They subsequently rescored
the profiles by only eliminating the five items, again finding nonsignificant mean group
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differences. The authors stated that the Gass correction procedure should therefore not be
used in forensic neuropsychological examinations.
Purpose o f Current Study
To date, there has been no published research examining the effectiveness of
MMPI-2 neurological correction scales as indicators of possible simulation of cognitive
impairment. It is thought that the neurocorrection scales carry a unique “operating
profile” given their neurologically specific content. Unlike the Dunn and Lees-Haley
(1995) study, this study utilizes the neurocorrection scales as independent ordinal scales,
and not a “correction” procedure by eliminating items from the standard profile.
This study examines the ability of each of the published head injury neurocorrection
scales to differentiate TBI simulators and student controls. It utilizes a comparison group
of archival patients with documented mild to moderate head injury to test if the scales can
differentiate between TBI simulators and community TBI patients.
However, the main purpose of the current study is to compare the most effective
neurocorrection scale against the Fake Bad Scale in a simulated TBI malingering
paradigm. If the hypotheses are correct, this study will provide grounds for further
investigation on the clinical utility of the neurocorrection scales beyond profile analysis.
It could also call into question the use of the MMPI-2 in forensic neuropsychological
examinations. Specifically, it will draw attention to the practice of using self-report
inventories developed on psychiatric patients for assessment with neuropsychological
populations.
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Hypotheses
The first hypothesis concerns the ability o f the neurocorrection scales to
differentiate TBI simulators from controls effectively. Although the Gass (1991) scale
has the most published research focused on its sensitivity to head injury, this study will
instead predict that the Van Balen et al. (1997) scale will be able to predict simulators of
cognitive impairment above the other scales. This hypothesis is based on the premise that
the scale is derived from the complete MMPI-2 item set, compared to the 370-item
version of the Gass (1991), and Gass and Russell (1991) scales. The scale also reflects
item content that was endorsed by at least two professionals from the field of neurology,
neuropsychology, psychiatry, and physiatry as pertaining to head injury sequelae. Thus,
individuals who intend to express cognitive impairment might endorse items that, on the
surface, reflect cognitive content consistent with bona fide mild head injury (Huskey,
2004) and, popular misconceptions of head injury symptoms (Guilmette & Paglia, 2004;
Swift & Wilson, 2001).
The second hypothesis concerns the effectiveness of the correction scale(s) when
compared to the Fake Bad Scale. It is predicted that the most effective neurocorrection
scale will outperform the Fake Bad Scale in the ability to differentiate effectively TBI
simulators from actual TBI patients. This prediction is based on the premise that the
neurocorrection scale will be more likely to detect cognitive symptomatology, as opposed
to the FBS, which was developed to detect emotional and somatic distress (Lees-Haley,
et al., 1991).
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Method
Participants
University o f Montana undergraduate psychology students were recruited during
the spring and summer sessions of the year 2005. Sixty students were randomly assigned
to either a TBI simulation or control group. Students were allowed to participate if they
were 18 years o f age or older and current psychology students at The University of
Montana. The 60 students received 3 credits toward their respective courses for
participation. Student information sheets were then screened and protocols excluded from
the final analysis if participants endorsed a history of neurological or psychiatric
treatment. Specifically, students were eliminated if they reported a history of any mood
related disorder, anxiety condition, substance abuse, Attention Deficit Hyperactivity
Disorder (ADHD) migraine headache, a seizure condition, or a mild to moderate head
injury. After screening, the sample included 15 students in the TBI simulation group and
17 students in the control condition. Every other student was assigned to the TBI
simulation group until 30 participants for each group completed the MMPI-2.
Thirty archival files from community TBI patients were also collected. The same
inclusion criteria applied for this group, age 18 years or older and a completed full
MMPI-2. Additionally, informed consent must have been documented in their records
and have met the clinical criteria for a mild to moderate head injury. The sample was
taken from records between the years 2002-2005. After screening for the prior
neurological and psychiatric conditions mentioned above, the inclusive sample served as
a clinical comparison group (n = 22).
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Determining the Severity o f Head Injury
The severity of head injury was defined according to one of three possible injury
variables (see appendix D). Measures of injury severity consisted of the length of time
one experienced a loss of consciousness (LOC) due to a blow the head, length of time
one experienced post-traumatic amnesia (PTA), or score on the Glascow Coma Scale
(GCS; Williamson, Scott, & Adams, 1996). For mild head injury, the criteria consist of a)
LOC for less than 20 minutes, b) PTA of less than 24 hours, and c) GCS of 13-15. For
moderate head injury, the criteria consist of either a) LOC of 20 minutes - 36 hours, b)
PTA o f 1-7 days, and c) GCS of 9-12 (DeKruijk, Twijnstra, & Leffers, 2001). An
individual was required to have met one of the criteria to be included in the current study.
Materials
The 567-item version of the MMPI-2 was administered or collected from each
participant. Validity and Clinical scale raw scores were transformed into uniform T scores for validity and K-corrected Clinical scales. Raw scores from five neurocorrection
scales and the Fake Bad Scale were also computed.
MMPI-2 Validity Scales
The validity scales included the family of F scales typically used to identify over
reporting of psychiatric symptoms. The scales included the F (Infrequency) scale, which
measures the frequency of items that are symptoms rarely experienced by psychiatric
patients; F(b) - Back Infrequency, which consists of items of infrequent psychiatric
symptoms for the last half of the MMPI-2; and F(p) - Infrequency Psychopathology
(Arbisi & Ben-Porath, 1995), which is a measure of infrequent symptoms endorsed by no
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more than 20% of a sample of psychiatric inpatients. Two other validity scales that
measure under-reporting of psychopathology were included. The Lie scale (L) is a
measure of defensiveness defined as a refusal to admit even minor faults, and the
correction scale (K) which is a measure of subtle or sophisticated attempts to present
oneself favorably (Meehl & Hathaway, 1946).
Finally, consistency of item endorsement was measured by including the Variable
Response Inconsistency (VRIN) scale and the True Response Inconsistency (TRIN) scale
(Butcher, et al., 1989). The VRIN scale consists of 67 pairs of items that have similar or
opposite item content. The TRIN scale measures whether the respondent answered the
item pairs as either “true” or “false” (Greene, 2000).
MMPI-2 Clinical Scales
The ten clinical scales, in order, are contemporarily referred to by their numerical
codes. These are Scale 1 - Hypochondriasis, 2 - Depression, 3 - Hysteria, 4 Psychopathic Deviate, 5 - Masculinity/Femininity, 6 - Paranoia, 7 - Psychasthenia, 8 Schizophrenia, 9 - Hypomania, and 0 - Social Introversion.
Scale 1 reflects a wide variety o f nonspecific somatic concerns. Somatic areas
include complaints regarding the abdomen and back, and persist despite negative medical
evidence. It must be noted that individuals who are actually ill will obtain moderate
elevations. High scorers on this scale, if physically ill, will also tend to have
hypochondriacal features associated with their illness (Greene, 2000). Personality traits
often include self-centeredness, demandingness, cynicism, and stubbornness
(deMendonca, et al., 1984).
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Scale 2 is characterized as a diverse scale that includes features of poor morale,
worry, self-punishing, hopelessness about the future, and dissatisfaction with one’s life
(deMendonca, et al., 1984; Graham, 2000). There are also items that reflect physical
symptoms, such as sleeplessness and gastrointestinal problems. The scale also includes
content related to apathy, psychological sensitivity, and social withdrawal. Greene (2000)
states that scale 2 is a difficult scale to interpret in isolation given its many factors.
Scale 3 was developed on patients either diagnosed with Hysteria with what
currently be called Histrionic Personality Disorder. Item content reflects somatic
symptoms in the head, arms, and legs, as well as a perception of social adjustment.
Persons with high scores on this scale are friendly, self-centered, demanding, immature,
and suggestible (deMondonca, et al., 1984) and only avoid responsibility and develop
conversion symptoms when under overwhelming stress (Greene, 2000).
Scale 4 was developed on young adults who were diagnosed with a “psychopathic
personality” (McKinley & Hathaway, 1946). The scale typically represents social
maladjustment and a lack of pleasant experiences. Poor impulse control, emotional
shallowness, a disregard for social conventions, and hostility towards authority figures
are features that describe high scorers.
Scale 5 measures gender stereotypes and was developed to detect potential
homosexual trends when homosexuality was once considered a psychiatric disorder by
the American Psychiatric Association (APA) as indicated in the second edition of the .
Diagnostic and Statistical Manual of Mental Disorders (DSM-II, see APA, 1968). This
scale is not considered a “clinical” scale and will not be included in the analysis.
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Scale 6 represents item content reflective of interpersonal sensitivity, selfrighteousness, and suspiciousness (deMondonca, et al., 1984). The scale does not
represent pure cases of paranoid individuals, but rather individuals who were deemed to
be in a paranoid state, including persons diagnosed with “paranoid schizophrenia” or with
a “paranoid condition” (Greene, 2000, p. 155).
Scale 7 is generally considered a measure of psychological discomfort and
turmoil, with high scorers often experiencing obsessive thinking and serious levels of
insecurity (Graham, 2000). The condition of “psychasthenia” is contemporarily
conceptualized as obsessive-compulsive disorder. But rather than tapping specific
behaviors or rituals, the scale reflects personality characteristics such as interpersonal
sensitivity, neuroticism, anxiety, and social withdrawal, as well as poor physical health
(deMondonca, et al., 1984; Graham, 2000).
Scale 8 reflects the most diverse Clinical scale given its seven factors. The scale
taps a wide variety of symptoms that include “paranoia, concern about sex, sensitivity to
rejection, psychotic tendencies, poor concentration, poor health, and social withdrawal”
(Graham, 2000). Additional characteristics include confusion, worry, imaginativeness,
unconventional attitudes, and impulsiveness (deMondonca, et al, 1984). Not only can
high scoring protocols be related to the above variables, elevations will also be produced
by individuals with neurological impairment such as epilepsy (Bomstein & Kozora,
1995).
Scale 9 was derived from psychiatric patients who demonstrated characteristics of
hypomania. Hypomania is characterized on the MMPI-2 as disturbances in “activity
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level, excitability, irritability, and grandiosity” (Graham, 2000, p. 82). Specifically, high
scorers endorse items that describe accelerated psychomotor behavior and speech,
irritable and depressed mood, and flight of ideas. The scale is sensitive to the effects of
age, with elderly populations often producing scores below average, and ethnicity, with
American Indian/Alaska Native, Hispanic, and African-American groups scoring on
average higher than Caucasians (p. 82). High scorers on this scale are typically viewed as
having excessive energy and a tendency to manifest an unrealistic self-appraisal.
The study will also include scale 0 although this scale was not developed on a
particular patient group. Rather, it was developed to represent the continuum of
personality traits of social introversion - extroversion. The scale should not be interpreted
in isolation due to its development on university students, but it can provide useful
information when additional scale elevations are observed (Graham, 2000).
Five MMPI-2 Neurocorrection Scales
Five neurocorrection scales were used in this study. Three of the scales were
derived through empirical methods and two were developed from a rational approach.
The Gass (1991) 14-item scale comprises items that were derived through Principle
Components Analysis. The oblique rotation yielded a two factor solution for the 370-item
version of the inventory. The first factor included 28.4% of the overall variance and was
labeled “neurological complaints” (p. 29). The items represented neurological symptoms
of cognitive inefficiency, muscle weakness, tremor, and speech related content.
The Alfano et al. (1993) 13-item scale was also derived through Principle
Components Analysis but the analysis was conducted on the full 566-item MMPI. This
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scale accounted for 25% of the overall variance and was labeled a “neurobehavioral”
factor. The items contained neurological symptom complaints related to poor attention,
sensory and motor dysfunction, or problems with psychosocial adjustment such as
vocation or with sexual satisfaction.
The Artzy (1996) 17-item TBI scale was another scale in which Principle
Components Analysis was used to derive a head injury factor. Artzy compared patients
with head injuries to patients with chronic pain. The subsequent TBI factor accounted for
28.5% o f the overall variance and represented item content such as dizziness, attention
and concentration problems, and poor psychosocial adjustment.
The rationally derived Gass and Russell (1991) 42-item scale predated the
aforementioned Gass (1991) study. An innovative approach was used instead of the
empirical method. The authors had professionals in the field o f neurology select items
that could possibly represent common “physical, not emotional” sequelae for brain
damage (p. 255). This approach of using professionals to select items based on their
content and clinical representation of symptoms is referred to as a rational method. The
neurological items in this scale are represented in the MMPI-2 Harris-Lingoes subscales
(Gass & Russell, 1991).
Instead o f adopting the usual procedure of deleting the items from the profile,
Gass and Russell assigned a weighted score to neurological related items. The weighted
scores were based on the ratio of non-neurologically related items that were endorsed in
each Clinical scale. The weighted scores were entered into the overall scoring of each
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scale. The Clinical scales were then K-corrected. This procedure allowed for scale
adjustment without the potential psychometric pitfalls associated with item deletion.
Finally, the Van Balen et al. (1997) 22-item scale was also derived through
rational methods. Forty experts from four professions that commonly treat patients with
central nervous system (CNS) related impairments were asked to imagine patients with
CNS dysfunction in general and identify items that could possibly reflect common
symptoms. Then, the judges were asked to do the same with 3 major patient groups,
namely “TBI, stroke, and whiplash” (p. 358). The items that obtained inter-rater
agreement levels of 70% or higher and were endorsed by at least two different
professions were selected as indicative of a particular patient population.
Procedure
Each student was given instructions in a private room by a trained research
assistant. Participants assigned to the control group received standard instructions as
indicated in the MMPI-2 clinical manual (Butcher, et al., 1989). Participants assigned to
the TBI simulator group were provided with instructions in which participants were
instructed to simulate a mild to moderate head injury (see appendix F). Participants in the
TBI simulator group were also told to imagine that they had experienced a head injury in
a motor vehicle accident. Additionally, TBI simulators were to take the MMPI-2 as part
o f the legal process for obtaining maximum financial compensation for their injuries.
Finally, even though their injuries were to have diminished, they were to answer the
questions from the MMPI-2 in a manner that suggested they were continuing to
experience the effects of a head injury. As a measure of response set, student TBI
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simulators were asked if they put forth maximum effort to simulate symptoms of a head
injury. All student participants received the allotted credit regardless of their ability to
simulate a head injury. Completed MMPI-2 protocols were obtained on the community
TBI group where informed consent to participate in research had been documented in
their clinical record.
Analysis o f the Data
In order to examine the utility of the neurocorrection scales as possible indicators
o f TBI simulation, a series of data analyses were conducted to answer the following
research questions:
1) Can MMPI-2 neurocorrection scales detect simulated cognitive impairment in
a compensation seeking paradigm?
2) Can MMPI-2 neurocorrection scales differentiate between groups of analog
TBI malingerers, actual TBI patients, and controls?
3) Can MMPI-2 neurocorrection scales classify group membership equal to or
better than the Fake Bad Scale?
Data procedures involved generating descriptive statistics for demographic
variables age, years of education, gender, and ethnicity. Means, standard deviations, and
results from one-way analysis of variance (ANOVA) and the Tukey honestly significant
difference (HSD) test were computed to detect group differences on MMPI-2 Validity
and Clinical scales (see appendix H-I). ANOVA, Tukey’s HSD, and overall measure of
association expressed as eta-squared (q2) for neurocorrection scales were also conducted
to ascertain group mean differences.
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Effect Size Contrasts o f Neurocorrection Scales
In order to answer the question of whether the neurocorrection scales could
differentiate between the three groups, a series of pairwise effect size contrasts were
conducted. The first contrast determined what neurocorrection scale was clinically
sensitive to TBI simulation, as well as meeting the selection criteria for entry into the
classification analysis. The next two contrasts answer the research questions regarding
whether the neurocorrection scales could differentiate community TBI patients and
controls, and TBI simulators and community TBI patients. In order to measure the
magnitude of separation, a converted Cohen’s d effect size statistic was calculated with
pooled standard deviations based on unequal group sizes (Zakzanis, 2001).
Cohen’s d is the estimated difference between the target and non-target group
means calibrated in pooled standard deviation units (Cohen, 1988). This statistic has been
deemed the most appropriate measure of effect size because it does not assume
homogeneity of variances among groups, and is calculated independently o f sample size.
Zakzanis’ (2001) approach converts standard Cohen’s d statistics to display the degree of
test score overlap between the two groups being compared by subtracting the amount of
test score nonoverlap from 100. Percentages of test score overlap between the groups can
be contrasted with effect sizes, and it ranges from 0-4. A converted effect size of 0 would
be interpreted as “no effect” and an effect size of 4 would represent “absolute
discriminability” (Zakzanis, 2001, p.658).
This study used the clinical significance marker of 3.0, which converts to 7%
overlap between groups on a particular test measure. This implies that 93% of the target
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group participants actually produced test scores that were not produced by non-target
group members (Zakzanis, 2001). Calculation of effect sizes using pooled standard
deviations for unequal group sizes were used to answer research questions one and two.
Classification Analysis
Binary logistic regression analyses was conducted to answer question three
regarding the ability of the best neurocorrection scale(s) to classify TBI simulators
compared to the FBS. Logistic regression does not assume homogeneity of variance
among groups and is based on the odds that a random score on a given measure will be
classified as in the target category (Grim & Yamold, 2001).
In this analysis, the best neurocorrection scale and the FBS were the independent
variables, while group membership was the dependent variable. The analysis generated
odds ratios that represented the likelihood a random participant’s score would be
classified as coming from the target group. Unstandardized regression coefficients (B)
represented the nonlinear transformation of the predictor for a binary or dichotomous
dependent variable (Cohen et al., 2004). Since this study was aimed at determining the
effectiveness of the neurocorrection scales to detect TBI simulation, the target group for
the analysis was the TBI simulator group.
Operating Statistics
Sensitivity, specificity, and overall correct classification percentages were
conducted for the best neurocorrection scale and the FBS. Sensitivity refers to the
percentage correctly classified target group members. Specificity is the percentage of
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correctly classified non-target members. Hit rate refers to the overall correct classification
percentages, a combination of sensitivity and specificity rates.
Results
Results o f Demographic Variables
Table 1 displays group means for age and years of education. Significant age
differences were observed among groups, [F(l, 54) = 31.7, p < .001, r\2= .55]. Tukey’s
HSD test revealed that the TBI simulator and control groups were significantly younger
than the community TBI group. However, there were no significant differences found
between the TBI simulator and control groups. There were no significant differences in
years o f education across groups, [F (2, 54) = .03,p = .97, D2= 01]. Out of the 15 TBI
simulators, 100% stated that they put forth maximum effort while simulating a head
injury.
Table 2 presents gender and ethnic composition of each group. Gender
composition did not differ significantly across groups, y 2(2) = .04, p = .98. Essentially
each group had identical female-to-male percentages. All groups were approximately
two-thirds female with just over one-third male. The total sample composition was 65%
female and 35% males. Additionally, there were no significant differences in ethnic
•

•

2

•

composition across groups, % (6) = 5.9,p = .43. The TBI simulator group was 100%
Caucasian, controls 91% Caucasian, and the community TBI group approximately 94%
Caucasian.
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Analysis o f Variance Comparing Groups on MMPI-2 Neurocorrection Scales
Analysis of variance procedures were computed for the neurocorrection scales
across groups. All scales produced significant mean differences and are displayed in
Table 5.
Significant mean differences were observed on the Gass (1991) scale, [F (2, 54) =
34.1, p < .05, r|2= .57]. Tukey’s HSD revealed significant differences between both TBI
simulators and community TBI patients compared to controls,/) < .05. No significant
differences were observed between the TBI simulators and community TBI patients.
Significant differences among the 3 groups were observed on the Alfano scale, [A
(2, 54) = 28.1 ,p < .05, r|2- .53]. Both TBI simulators and community patients differed
from controls,/? < .05, but not between the simulator and TBI patient groups.
The Artzy scale revealed significant group mean differences, [F (2, 54) = 13.7,p
< .05, r| = .35]. TBI simulators differed significantly from controls and community TBI
patients,/? < .05, but did not differ between community TBI patients and controls.
The Gass and Russell (1991) scale revealed significant differences among groups,
[A (2, 54) = 27.3,/? < .05, rj2 = .52]. Both TBI simulators and community patients differed
from controls,/? < .05, but did not differ between each other.
The Van Balen scale also revealed significant mean differences among the 3
groups, [A (2, 54) = 33.3, p < .05, r\2= .57]. Tukey’s HSD revealed the TBI simulators
differed significantly from control subjects, p < .05, but not from community TBI
patients. Similarly, community TBI patients differed from controls,/? < .05, but not TBI
simulators.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

30
The FBS was also included in a one-way ANOVA procedure. The FBS produced
significant differences among groups, [F (2, 54) = 20.3, p < .05, r\2 = .44]. It was the
only validity scale that did not produce significant differences among scores for the TBI
simulators and the community TBI group. However, both TBI simulators and community
TBI patients did differ from controls,/) < .05.
A description of group differences on the Basic scales can be in the appendix H.
The Validity scales demonstrated significant group differences on the family of
Infrequency scales (see appendix I). The typical profile on the MMPI-2 Clinical scales
for patients with mild head injury, and involved in compensation litigation, was
replicated in this study (see appendix J).
Differential Ability o f the Neurocorrection Scales
In order to address the question regarding using the neurocorrection scales to
differentiate between TBI simulators and controls, a pairwise effect size contrast utilizing
a converted Cohen’s d effect size estimate based on unequal group sizes was calculated
for each scale (see Table 6). The results indicate that Alfano’s scale produced the only
effect size to reach the clinical significance marker of 3.0 (d = 3.3). The large effect size
indicated a 4% overlap between neurocorrection scores between the two groups.
All of the remaining neurocorrection scales produced moderate effects. The Gass
scale produced a moderate effect size of d - 2.9, indicating a 7.0 % test score overlap.
Artzy’s scale produced a moderate effect size of d= 2.0, indicating 18.9% overlap among
scores between the two groups. The Gass and Russell scale also yielded a moderate effect
size (d = 2.7) that indicates 9.5% test score overlap. The Van Balen scale produced an
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effect size in the moderate range (d= 2.8) that translates into an 8.8% overlap in group
scores.
In order to examine whether the neurocorrection scales are able to differentiate
between community TBI patients and controls, a second series of effect size contrasts
were conducted (see Table 6). Results indicated that there were no clinically significant
effect size estimates produced by the scores. Gass and Russell’s scale obtained a
moderate effect size (d= 2.4) with 13% scale score overlap. Van Balen’s scale also
produced a moderate effect size (d= 2.3) that translates into 17.1% test score overlap.
The Gass scale also produced a moderate effect size, (<7= 2.4), indicating 15.7% score
overlap. The Alfano scale and the Artzy scale produced small and no effects (d ’s = 1.5
and .50, respectively).
A final contrast was conducted in order to examine the ability of the
neurocorrection scales to differentiate TBI simulators from community TBI patients.
Results revealed that most neurocorrection scales produced trivial effect sizes between
group scores. The exception was the small effect size produced by Artzy’s scale (d= 1.3),
which represents 34.7% of overlap between group scores on this scale (see Table 6).
In order to be included in the analysis comparing the classification ability against
the FBS, neurocorrection scales must have met or exceeded the clinical significance
marker for effect sizes (3.0; Zakzanis, 2001). The Alfano scale was the only scale to
reach clinical significance, d = 3.3. Therefore, the Alfano scale was selected as the only
neurocorrection scale to be compared to the FBS in the classification analyses.
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Classification Results o f Logistic Regression Analyses
Table 7 displays two separate binary logistic regression procedures examining the
classification ability of the Alfano neurocorrection scale and FBS. Results from logistic
regression revealed TBI simulators were .21 times more likely to classified as simulators
'j

than controls using the Alfano scale, Wald % (1, 32) = 4.3, p = .04. The second logistic
regression procedure examining the FBS revealed that TBI simulators were .56 times
'j

more likely to be classified as a simulator than a controls, Wald % (1, 32) = 8.8, p = .003.
Table 8 displays frequency counts for observed and predicted group membership.
The Alfano scale correctly classified 13 of 15 TBI simulators and 16 of 17 control
subjects. The FBS correctly classified 11 of 15 TBI simulators and 14 out of 17 controls.
Effect Size Comparison Between Alfano and the FBS
Table 9 presents Cohen’s d effect size contrast for the FBS examining the degree
of test score overlap compared to the Alfano scale. The FBS produced a small effect size
of 1.8 which translates into a 22.6% test score overlap. In other words, 22.6% of scores
on the FBS were shared among both groups, compared to approximately 5% overlap on
the Alfano scale. All of the neurocorrection scales produced effect sizes larger than the
FBS when differentiating TBI simulators from controls.
Sensitivity, Specificity, and Overall Hit Rate
Table 10 displays the sensitivity, specificity, and overall correct classification
rates o f both scales while using cutoff scores based on their harmonic means. The Alfano
scale classified 86.7% of the TBI simulators correctly while classifying 94.1% of the
control subjects correctly for an overall hit rate of 90.6%. Comparatively, the FBS
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classified 78.3% o f the TBI simulators while classifying 82.4% of the control subjects for
an overall hit rate o f 78.1%. Both scales were able to classify control participants at a
higher rate than TBI simulators.
Discussion
Performance o f Neurocorrection Scales Compared to the FBS
Previous research has focused on the FBS as a measure of exaggeration on the
MMPI-2 in neuropsychological evaluations. This study provides the first evidence
suggesting that the MMPI-2 neurocorrection scales are superior to the FBS as measures
o f TBI simulation. In fact, all of the neurocorrection scales produced effect sizes larger
than the FBS. This substantiates the research hypothesis that the neurocorrection scales
would be more sensitive to head injury simulation than the FBS. A major impetus for
testing this hypothesis is due to the scales design for identification of cognitive
complaints. This study hypothesized that the neurocorrection scales would perform as
good as or better than the FBS, which is designed to detect somatic and emotional
exaggeration.
Measures taken to improve both internal and external validity included using
homogenous groups in which prior histories of neurological and psychiatric conditions
were excluded, as well as adding a comparison group of community patients with
documented mild to moderate head injury as a comparison group. The instructions for the
simulator group were purposely left symptomatically ambiguous in order to limit the
degree o f “coaching” provided to TBI simulators. In addition, effect size contrasts were
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employed in order to compensate for high degrees of score variability between the
simulator, TBI, and control groups, as well as unequal group sizes (Zakzanis, 2001).
Artzy’s scale produced a small effect size differentiating TBI simulators from
community TBI patients. However, the 35% overlap of scores is unacceptable in clinical
practice. On a side note, the FBS produced an effect size that translated into
approximately 66% score overlap between these two groups. The latter result is
consistent with previous studies in that the FBS largely over-estimates malingering of
neurological symptoms (Butcher et al., 2003).
The Influence o f Prior Probabilities and Base Rates
One important feature o f classification studies is the prior probability rates for
identifying a certain condition. Prior probabilities are based on base rates, or the
likelihood that any given individual will be classified with a specified condition in a
particular setting. It has been demonstrated that differences in base rate percentages
across settings can influence the sensitivity and specificity rates of classification.
The current study had a base rate of malingering o f 28%. This is well within the
reported range of 15% - 40% base rates reported in previous studies (Binder & Willis,
1991; Fox, et al., 1995; Lees-Haley & Brown, 1993; Mittenberg, et al., 2002). Overall
correct classification of 78% for the FBS in the current study was slightly higher than the
Dearth et al. (2005) study in which the FBS achieved an overall hit rate of 73%. It was
also similar to the Butcher et al. (2003) study that found up to 30% over-prediction of
malingering by the FBS.
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Previous studies on the FBS have also reported classification results considering
alternative cutoff scores and base rates. The contrast in this study between simulators and
controls utilized a cutoff o f 7 for the Alfano and 18 for the FBS. When the cutoff scores
were adjusted for the Alfano scale to 8 and 10, the result was a higher rate of classifying
control subjects; however, the sensitivity to malingering was lowered. This result is
attributable to the fact that 3 of the simulators produced scores of 7 or below on this
scale. Therefore, the elevation of the cutoff score did nothing to improve the sensitivity to
TBI, only improving the identification of non-brain injured subjects.
Similarly, previous studies have suggested cutoff scores between 21 and 26 for
the FBS. In the current study, a cutoff of 18 was used in the analog malingerers and
control contrast that produced the most effective classification levels. In fact, the mean of
18 for the simulator group was actually lower than the mean of 21 for the TBI group.
This finding is consistent with previous studies in that the FBS appears to be capturing
item content related to somatic and emotional maladjustment rather than cognitive
impairment. Consequently, when used to differentiate groups of malingerers from actual
TBI patients, the FBS will tend to classify those individuals with bona fide TBI as
malingerers.
This finding is somewhat expected, given the instructions of the current scenario
referred to being “knocked out and dazed” rather than suggesting specific emotional and
physical symptoms. Research on common misconceptions of brain injury symptoms by
the general public and neurological patients consistently finds that that people tend to
overestimate the degree of injury related to mild head injuries as well as overestimate
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premorbid psychological health and cognitive ability (Coolidge, et al., 1998; Mittenberg,
et al., 1991; Williams, et al., 1998). In addition, it remains a diagnostic dilemma that
post-concussive symptoms are not specific to mild head injuries and have been reported
to occur in the general population at rates as high as 75% within a two week period
(Iverson & Lange, 2003).
Performance o f MMPI-2 Validity Scales
Considering the performance of the MMPI-2 Basic scales, the family of F scales
surprisingly, differentiated TBI simulators from controls and community TBI patients.
Like the Dearth et al. (2005) study, the F scale may indeed show promise in detecting
simulated TBI. Perhaps it would have outperformed the FBS in this study given that the
mean score of community TBI patients exceeded the TBI simulators on the FBS, but
were not significantly different.
Performance o f MMPI-2 Clinical Scales
The pattern o f elevation on the Clinical scales was generally consistent with
previous research in the area. In addition to the well documented elevations on scales 1,
2, 3, 6, 7, and 8. Additional differences were observed on scale 0. MMPI-2 Clinical
scales 6 and 8 obtained significant differences among all three groups. These results are
generally consistent with previous research examining MMPI scores with groups of
analog cognitive malingers and persons involved in financially compensable litigation for
head injuries (Berry, et al., 1995; Heaton, et al., 1978; Larrabee, 2003; Ross, et al., 2004).
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Applications o f Neurocorrection Scales fo r Clinical Practice
The clinical practice of evaluating individuals who might be suspected of
malingering in neuropsychological contexts involves a multidimensional procedure that
utilizes tests that have been validated for this purpose (Iverson & Binder, 2000). The
MMPI-2 is most often used in these circumstances to enhance clinician sensitivity for
individuals who may exaggerate their cognitive complaints. The neurocorrection scales
may offer an improved method of detecting cognitive exaggeration.
Considering the neurocorrection scales and their ability to differentiate between
TBI simulators and community TBI patients, the Artzy scale produced a clinically small
effect. Approximately 35% of the scores on this scale were produced by both TBI
patients and the simulators. Although this figure is unacceptable in clinical practice, it is
approximately half the percentage than the overlap generated by the FBS (66%).
However, more research needs to be directed at validating the neurocorrection scales as
measures of cognitive exaggeration.
Limitations o f the Current Study
There are a number of limitations associated with the current study. Due to the
small sample size, it is possible that if there were additional participants, results would
have produced coefficients that were more robust and not subject to variability due to low
power. This may have proven that more than just one neurocorrection scale would have
demonstrated clinically significant effect sizes for comparison against the FBS.
This study also employed the use of research credits as an incentive that were part
of the course requirements in which the students were recruited. A more realistic

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

38
monetary incentive such as those used by Dearth et al. (2005) may have produced better
over-reporting response sets by the simulator group. Using archived records dating 2-3
years prior to the study may have also influenced test scores. Using a randomized design
for the TBI group at the time of evaluation, additional screening measures, and
temporally consistent data would decrease threats to internal validity.
There are also inherent weaknesses with using analog designs compared to
known- group designs. The primary feature limiting the generalizability of analog studies
is the inability to simulate real-world forensic contexts. On the other hand, analog studies
can, by randomization, exert a certain degree of control over experimental variables
(Rogers, 1997).
Implications fo r Future Research
This study was limited by a number of factors; however, some significant and
interesting findings did emerge and are worthy of further examination. The
neurocorrection scales outperformed the FBS in the TBI simulator versus control
contrast. This is the first study to look at the effectiveness of these scales for this
particular purpose and, as a result, preliminary evidence suggests that the scales may
improve the state of affairs when attempting to identify TBI simulation rather than the
FBS. It also appears that the neurocorrection scales contain a different operating profile
compared to the FBS, which captures a different set of symptoms and deceptive strategies
rather than just simulation of cognitive impairment.
This study suggests it may be more prudent to employ neurocorrection scales in
lieu of the FBS for patients who complain of late effects of mild head injury. Results
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from the current study suggest that at least one, if not a few of the neurocorrection scales,
may offer clinical utility in differentiating TBI simulators in forensic contexts. Future
studies might focus on adding comparison groups in addition to TBI, as well as employ
scenarios involving different levels of information provided to participants about TBI
sequelae.
For example, depression and emotional dysregulation become more salient as TBI
symptoms persist (Reitan & Wolfson, 1997). This information would likely influence the
sensitivity of the neurocorrection scales given their strict cognitive content. In addition,
using known-groups of probable malingerers would also provide interesting evidence of
the head-to-head comparability of the scales under real-world forensic contexts.
Lees-Haley, Iverson, Lange, Fox, and Allen (2002) explicitly state that the
MMPI-2 does not meet the criteria for legal admissibility of psychological tests regarding
neurological patients because it does not measure brain injury. This study perhaps
provides further evidence that the use of the MMPI-2 as an indicator of malingering in
forensic neuropsychological evaluation must be further explored. As Arbisi and BenPorath (2003) suggest, accurate normative studies aimed at cross-validating the
neurocorrection scales with the content and component scales of the MMPI-2 rather than
the clinical scales are needed. With the introduction of the MMPI-2 Restructured Clinical
(RC) scales and the common factor of “Demoralization” represented in scale D
(Tellegan, et al., 2003), another opportunity exists to examine profiles of patients with
various types of neurological compromise.
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Perhaps the most important question not yet investigated is, if one is using the
MMPI-2 in a forensic neuropsychological evaluation, how much weight should be placed
on it as a measure o f TBI simulation? Perhaps it is in the best interest o f the field of
psychological assessment to continue to pursue the answer to this question. It may also be
prudent to continue to examine novel and innovative strategies to detect cognitive
malingering. Perhaps the self-report format is too susceptible to deceptive responding,
particularly if the measure has items that are not specific to neurological conditions. It is
in this spirit that future studies evaluating the MMPI-2 in forensic neuropsychological
contexts consider using the various neurocorrection scales as indicators of TBI
simulation.
The current study suggests that there may be an alternative to the FBS in forensic
neuropsychological evaluations that employ the MMPI-2. It also demonstrated that the
neurocorrection scales do not meet standards that would consider them as valid measures
of cognitive malingering. In fact, the problem of symptom nonspecificity still remains,
even with the narrow neurocorrection scales. The item bias problem remains and calls
into question the clinical utility o f the MMPI-2 as a measure of neuropsychological
exaggeration in forensic evaluations.
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Tables

Table 1

Age and years o f education for three groups.

TBI

TBI Simulators

Student controls

Variable

Mean

SD

Mean

SD

Mean

SD

Age

21.6a

5.3

20.7a

3.3

40.9b

13.1

Education

12.8

3.1

13

2.8

13.23

1.96

Note: Means that do not share subscripts differ significantly at p = .05
level. Education represented in years.
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Table 2
Gender and ethnic compositionfor three groups.

TBI Simulators

Student controls

TBI

Frequency

%

Frequency

%

Frequency

%

Male

5

33.3

6

35.3

8

36.4

Female

10

66.7

11

64.7

14

63.6

Caucasian

15

100

14

82.4

20

91

American
Indian

0

0

1

5.9

2

9.1

African
American

0

0

1

5.9

0

0

Hispanic

0

0

1

5.9

0

0

Gender

Ethnicity
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Table 3
Analysis o f variance comparing groups on MMPI-2 neurocorrection scales and the FBS.

TBI simulators
(«= 15)

Student controls

TBI

ANOVA

(«=22)

(n~ 17)

Scale

n

Mean

SD

Mean

SD

Mean

Gass

14

10.3.

3.7

2.1b

1.8

7.5a

3.0

34.1*

.57

Alfano

13

9 .7 .

1.9

3.4b

1.9

7.1a

3.0

28.1*

.53

Artzy

17

11-la

2.2

6.4b

2.5

7.7b

3.0

13.7*

.35

Gass &
Russell

42

2 3 .5 .

4.9

12.4b

3.4

2 1 .5 .

5.2

27.3*

.52

Van Balen

22

12.9.

3.5

3.9b

3.1

13.5.

4.7

33.3*

.57

FBS

43

18.4.

3.7

11.7b

21.0,

6.0

20.3*

.44

3.6

SD

F (2, 54)

Note: n - number of items contained within each scale, if- eta-squared measure of effect size.
Means and standard deviations derived from raw scores. Means in the same row that do not share
subscripts differ significantly in the Tukey HSD comparison, * p < .05.
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Table 4
Pairwise comparison o f groups using converted Cohen's d effect size estimates for MMPI-2
neurocorrection scales and the FBS.

TBI Simulators v.
Controls

TBI v.
Controls

TBI Simulators v.
TBI

Gass

2.9

2.2

.86

Alfano

3.3*

1.5

.59

Artzy

2.0

.50

1.3

Gass & Russell

2.7

2.4

.40

Van Balen

2.8

2.3

.14

Fake Bad Scale

1.8

1.8

.51

Scale

Note: Pooled standard deviations based on unequal group size. Interpretation of effect sizes; 0-1:
minimal effect; 1-2: small effect; 2-3: moderate effect; and 3-4: large effect.
*Meets clinically significant criteria (Zakzanis, 2001).
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Table 5
Logistic regression analysis fo r Alfano and the FBS predicting group
membership.

Wald
Scale

Odds
ratio

B

SE

Alfano

-1.6

.78

4.3

.21

.04

FBS

-.52

.18

8.8

.56

.003

x2

P

Note: B - unstandardized regression coefficient. SE - standard error.
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Table 6
Classification frequencies fo r Alfano and the FBS

Predicted

Scale

Observed

TBI simulator

Control

Alfano

Simulator
Control

13
1

2
16

FBS

Simulator
Control

11
3

4
14

Note: Hit rate - overall percentage correctly classified.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

47
Table 7
Sensitivity, specificity, and hit rate fo r Alfano and the FBS.

Scale &
cutoff

Sensitivity

Specificity

Alfano ( > 7)

86.7

94.1

FBS ( > 1 8 )

73.3

82.4

Hit Rate

90.6

78.1

Note: Percentages for TBI simulators and student controls.
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Appendix A.
Participant Information and Consent Form
Title: The Effectiveness o f Special Correction Scales o f the MMPI-2
Investigators
Paul Dukarm, Dept, of Psychology, The University of Montana, Missoula MT. 59812
243-6347
Dr. Stuart Hall, Dept, of Psychology, The University of Montana, Missoula MT. 59812
243-5667
Special Instructions to the potential subject
Thank you for considering participating in this study. This consent form may contain
words that are unfamiliar to you. If the contents of this form are unclear, please as the
person who gave you this form to explain it to you.
Purpose
The purpose of the current study is to examine how effective certain scales contained
within a common measure of personality are at distinguishing between different types of
people . By signing the form below, you are giving your voluntary consent to participate
in this research study.
Procedures
As a participant in the current study, you will asked to provide “true” or “false” answers
to a variety of questions about personality features. Your answers to these questions will
be kept completely confidential. The personality form can take between 35 minutes to
approximately 1-1/2 hours to complete. Completion of the form will take place in the
Skaggs building, Room #246, located at the top of the stairs on the second floor, directly
above the psychology department.
Risks / Discomforts
As a research participant, it is expected that the amount of discomfort you will experience
as a result of this study will be minimal. It is possible that some of the questions on the
inventory may cause you to feel uncomfortable due to their personal nature. If you
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become uncomfortable, please feel free to discuss your concerns with the research
examiner or contact the principal investigator or faculty supervisor at the numbers
provided above. Additionally, you may feel fatigued due to the length o f the inventory. If
you feel as if you need to take a break from answering the questions, you will be allowed
to take a brief break when it is needed.
Benefits
Participating in the current study may benefit you by assisting you in obtaining three (3)
experimental research credits and providing you with exposure to scientific research in
psychology. Your participation will also provide very beneficial information to
researchers and professionals in the field of psychology.
Confidentiality
The information you provide will be held strictly confidential by the research examiners
(*see limitations below). Your name will not be marked on the answer sheet or
questionnaire. However, if you agree to participate in this study, you will need to sign
this form, which will be kept in a separate and locked filing cabinet from all testing
materials. We will have you note your age, gender, ethnicity, and years of education for
demographic purposes, but this personal information will not be attached to this form that
contains your name. All demographic information will be kept separate from your
response form, and will be used for data analysis purposes only. You will be assigned an
identification number that will be used to help the research team keep your data forms
organized. The information you provide will be read only by the principal investigator
(Paul Dukarm), the faculty supervisor (Dr. Stuart Hall), and individual research
assistants. Your answers to the inventory will be kept a minimum of 5-years after the
study has ended, however the demographic form will be destroyed at the conclusion of
the current study. The data from this study will be used for research publication purposes
only, as well as presentations for research at academic conferences.
*There are certain situations in which confidentiality may be breached. I f you indicate
that you have a desire to harm yourself or someone else during the course o f this
experiment. I f this situation occurs, you will be provided with information on where you
may obtain mental health services. Because o f this, we also require that you provide your
name and your telephone number below. I f you do not have a telephone number, please
indicate a phone number where you can be reached.

Print Name

Telephone Number
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Although there is minimal risk associated with your participation in this study, The University of
Montana requires that the following paragraph be included in all consent forms. “In the event
that you are injured as a result of this research you should individually seek appropriate medical
treatment. If the injury is caused by the negligence of the University or any o f its employees, you
may be entitled to reimbursement or compensation pursuant to the Comprehensive State
Insurance Plan established by the Department o f Administration under the authority of M.C.A.,
Title 2, Chapter 9. If the event of a claim for such injury, further information may be obtained
from the University’s Claims representative or University Legal Counsel. (Reviewed by
University Legal Counsel, July 6, 1993.”

Voluntary Participation / Withdrawal
Your participation in this study is entirely voluntary, and you may withdraw without penalty or
any negative consequences. If you choose to withdraw, all your records will be destroyed, ad the
data you provided will not be used in this study. If you decide to withdraw from this study, you
will still receive your experimental credits.

Questions
If you have questions about this study now or at any time during the examination, please feel free
to ask the examiner. Additionally, you may contact the principal investigator (Paul Dukarm, 2434521) if you have any further questions about the study. We will not be able to give you feedback
regarding your responses, however, you will be provided with additional information at the
conclusion of the study. This information will be presented in the form o f a debriefing sheet. If
you have any questions regarding your rights as a research participant, you may contact the
Institutional review Board Chair at 243-6670.

Subjects Statement of Consent
I have read the above description of this study and have been informed o f the benefits and risks
involved. All of my questions have been answered to my satisfaction, and I have been provided
with the principal investigators contact information and the faculty supervisor in the event that I
have concerns or questions in the future. By signing below, I voluntarily agree to participate in
this study and give my consent to the examiners to use the information I provide for the purposes
o f this experiment.

Participant’s name - Printed
Participant’s signature

Examiner’s signature
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Appendix B.
UM Participant Information Form

Code

Age________

Please answer the questions below

Ethnicity: (Please Check One)
American Indian
Asian
African American
Hispanic
Caucasian

_________
______
_ _ _ _ _
_________

Years o f Education

M M PI-2 Basic Scales T-Score

L ____
F ___
K ____
1
2 ____

Have you ever experienced a head injury or
other neurological condition (e.g. concussion,
seizures, migraines)? Y es
No
.
Please explain. LOC
PTA______

Have you ever seen a psychiatrist,
psychologist, or other mental health specialist
for psychological conditions? Y
N__
Please explain.

Special Correction Scales - Raw
Gass
Gass & Russell
Van Balen et al.

3____

4 ____
5 ____
6____
7
8____
9 ____
0

Alfano et al.
Artzy

(Research staff only) Manipulation check: YES

NO
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Appendix C.
MPM Participant Information Form

Code
Age

Neurological Data

Ethnicity: (Please Check One)

LOC

American Indian
Asian
African American
Hispanic
Caucasian

PTA
GCS
PTS yes

no

Years o f Education

MMPI-2 Basic Scales T-Score

Neurocorrection Scales - Raw

L
F
K

Gass

1
2
3
4
5
6
7
8
9
0

Van Balen

Gass & Russell

Alfano
Artzy
FBS
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Appendix D.
Head Injury Severity Classification Criteria

Traumatic Brain Injury

Measure

Mild

Moderate

Loss of Consciousness

< 20 minutes

20 minutes - 36 hours

Post-traumatic Amnesia

< 24 hours

1 - 7 days

Glascow Coma Scale

13-15

9-12

Adapted from Williamson, Scott, and Adams (1996).
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Appendix E.
Instructions for Psychology Student Control Group.

Instructions will be read as follows:
" This inventory is comprised o f 567 items that require you to answer either "true" or
"false" to a variety o f questions regarding personal interests and behavior. Please read
each item carefully and completely fill in the appropriate circle on your answer form. It
is importantfo r the purposes o f this study that you answer the items as honestly as
possible, and i f you come to a statement that you are unsure, answer the item whether it
is "mostly true" or "mostly false". I f you have any questions, please ask the examiner.
When you are finished, please put your answer booklet in the envelope and turn it in to
the examiner.
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Appendix F
Instructions for Student Head Injury Simulation Group
" This inventory is comprised o f 567 items that require you to answer either
"true" or "false" to a variety o f questions regarding personal interests and behavior.
Please read each item carefully and completely fill in the appropriate circle on your
answer form.
While responding to the inventory, please pretend that you have experienced
brain damage from a head-on motor vehicle accident. You hit your head against the
windshield and were knocked out fo r about 15-minutes. Afterwards, you felt "dazed" so
you were hospitalized overnight fo r observation. Because the driver o f the car is at fault,
you have decided to go to court and obtain compensation from the person responsible.
During the next few months following the accident, the negative effects begin to
disappear. Your lawsuit has not yet been settled, and your lawyer has told you that you
may get more money i f you look like you are still suffering from brain damage.
As you pretend to be this accident victim, try to respond to each item as a patient
who is trying to appear brain damaged in order to get money from the lawsuit. Your
performance on the inventory should convince the examiner as well as the people
involved in deciding the outcome o f your lawsuit that you are still suffering from brain
damage. I f you are able to convince the examiner o f your condition, you will be given an
extra (3) research credits fo r your participation.
Note: Instructions adapted from Thombaugh (1997), Rose et al. (1995), and Huskey &
Hall (2003).
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Appendix G.
Debriefing and Referral

Instructions to Examiner for Debriefing:
"Thank you fo r your participation in this experiment. You have ju st provided us with
valuable information that will help us ascertain whether the inventory you ju st completed
is helpful in allowing clinicians to detect persons who deliberately fake brain damage on
tests ofpersonality. Although the study was a simulation o f neuropsychological
impairment and litigation, the information you provided will nonetheless provide us with
preliminary information regarding continued research in this are.
For control group:
As you were told prior to completing the MMPI-2, you will be given (3) research credits
for your participation.
For experimental group:
You will receive six (3) credits fo r your participation.

In the event that a participant has questions regarding the answers they provided or
requests psychological services, they will be provided with the following
information.
Contact and Referral for Psychological Intervention
Project Coordinator - Paul Dukarm, M.A. 243-4521
Project Supervisor - Stuart Flail, Ph.D. 243 - 5667
CAPS - Counseling and Psychological Services - Curry Health Center
University of Montana, 243- 4711.
CPC - Clinical Psychology Center - 1444 Mansfield Ave., University of Montana,
243-2367.
WMMHC - Western Montana Mental Health Center - 1315 Wyoming, Missoula MT.,
532-9700
Providence Center - St. Patrick’s Hospital, Missoula, MT.
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Appendix H.
Results o f Analysis o f Variance Comparing Groups on MMPI-2 Validity and Clinical
Scales
Analysis of variance procedures for the Validity and Clinical scales were
conducted to examine the current results in relation to previous research. Specifically,
inspection of within and between groups differences on each scale would provide
evidence o f the consistency of scores related to previous studies examining TBI
simulators and controls.
Appendix I presents means, standard deviations, and results of one-way ANOVA
for MMPI-2 validity scales. Strength o f association between each validity scale and
group mean score is displayed as the eta-squared (r| ) effect size statistic. Tukey’s HSD
test post hoc alpha levels were conducted in order to evaluate significant differences for
each group pair. No significant differences between groups were observed on the VRIN,
TRIN, L, and K validity scales.
One-way ANOVA revealed significant differences among groups on the F scale,
[F (2, 54) = 38.9,p < .05, r\2 = .60], Tukey’s HSD revealed that the TBI simulators
differed significantly on the F scale from both controls and the community TBI patients,
p < .05. There were no significant differences observed between community TBI patients
and student controls.
Significant differences were also observed among groups for the F(b) scale,[ F (2,
54) = 18.7, /? < .05, x\ = .42]. Tukey’s HSD revealed significant differences between the
TBI simulators and both community TBI patients and controls,/? < .05. No significant
differences were observed between the community TBI patients and controls.
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The F(p) scale demonstrated significant differences among the 3 groups, [F (2,
54) = 9.1 ,/? < .05, scale r\2 = .26]. Tukey’s HSD indicated that the TBI simulators
produced mean scores that were significantly different from both the community TBI
patients and controls, p < .05. No significant differences were observed between the
community TBI patients and controls.
Analysis o f variance comparing groups on MMPI-2 Clinical scales
The one-way ANOVA results revealed significant differences on scales 1,2, 3,6,
7, 8, and 0 across groups and are displayed in Appendix J. Significant mean differences
were observed among groups on scale 1, [F (2, 54) = 47.3, p < .05]. Scale 1 generated a
large overall effect size across groups, r\ = .65. Tukey’s HSD revealed that TBI
simulators and community TBI patients differed significantly from controls,/? < .05, but
not from each other.
A one-way ANOVA revealed significant mean differences on scale 2, [F (2, 54) =
23.9,/? < .05, r \= .48]. Tukey’s HSD revealed that TBI simulators and community TBI
patients also differed significantly from controls,/? < .05. The TBI simulators did not
significantly differ from community TBI patients.
Significant differences were also observed across groups on scale 3, F (2, 54) =
21.2,/? < .05, t |2 —.45. As with the two previous scales, Tukey’s HSD revealed that the
TBI simulators and community TBI patients differed from controls,/? < .05, but not each
other.
No differences were observed between groups on scale 4. The ANOVA revealed
nonsignificant between group differences in mean scaled scores, [F (2, 54) = 3.9,/? = .05,
p 2 = .13].
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Significant mean differences among groups were produced for scale 6, [F (2, 54)
= 11.6,p < .05, r|2 = .41]. Tukey’s HSD revealed that TBI simulators differed
significantly from control and community TBI patients,/? < .001. Community TBI
patients significantly differed from controls,/? < .05.
Scale 7 also produced significant differences between groups, [F (2, 54) = 9.8,/?
< .05, r| = .28]. Tukey’s HSD revealed TBI simulators and community TBI patients
differed significantly than controls,/? < .05. TBI simulators did not significantly differ
from the community TBI patient group.
One-way ANOYA revealed significant differences on scale 8 across groups, [F
(2, 54) = 17.2,/? < .05, r|2= .40]. Tukey’s HSD revealed that the TBI simulators and
community TBI patients significantly differed from controls,/? < .05. Community TBI
patients also differed from controls and TBI simulators, p < .05.
No significant differences were observed between groups on scale 9. The
ANOVA revealed nonsignificant between group differences in mean scaled scores, [F (2,
54) = 3.8,/? = .05, r)2= .13].
Scale 0 produced significant mean differences among groups, [F (2, 54) = 7.1, p <
.05, r\2 = .22]. Tukey’s HSD test revealed that the TBI simulators and community TBI
patients significantly differed from controls,/? < .05. No significant differences were
found between TBI simulators and community TBI patients.
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Appendix I.
Analysis o f variance comparing groups on MMPI-2 Validity scales.

TBI Simulators

Student controls

TBI

(n=15)

(n=17)

(n=22)

ANOVA

Scale

Mean

SD

Mean

SD

Mean

SD

F(2, 54)

rf

VRIN

60.1

15.3

53.8

10.6

55.5

11.1

1.1

.04

TRIN

61.8

13.9

54.1

5.0

57.6

7.2

.9

.10

F

97.1.

20.9

57.l b

12.1

59.5 b

10.2

38.9*

.60

F(b)

91.1a

23.4

55.0b

21.1

56. lb

10.9

18.7*

.42

m

83.1a

26.8

55.8b

21.3

53.7b

18.6

9.1*

.26

L

53.1

12.8

45.5

12.6

55.0

10.2

3.7

.13

K

42.4

7.6

49.5

9.5

47.7

7.5

3.2

.11

Note: if- eta-squared measure of effect size. Means in the same row that do not share subscripts
differ significantly in the Tukey HSD comparison,* p < .05.
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Appendix J.
Analysis o f variance comparing groups on MMPI-2 K-corrected Clinical scales

TBI Simulators

Student controls

TBI

(n =17)

(n =22)

Mean

SD

Mean

SD

Mean

SD

IK

76.3a

13.0

40.2b

10.5

74.1.

2

77.0a

16.4

48.0

8.8

3

77.6a

16.0

50.2b

4K

62.5

14.4

6

80.3a

19.9

7K

62.9a

18.3

8K

81.l a

9K
0

r?

13.0

47.3*

.65

70.1,

12.3

23.9*

.48

9.1

79.4a

17.6

21.2*

.45

50.5

11.6

60.2

12.5

3.9

.13

8.9

62.2C

12.5

17.6*

.41

44.7a

14.5

66.1b

14.8

9.8*

.28

21.3

46.4b

16.3

66.6C

13.7

17.2*

.40

64.9

11.8

56.4

13.9

52.5

14.2

3.8

.13

59.7a

15.3

44.5b

7.5

52.0a

12.7

7.1*

.22

cr

F (2, 54)

©

Scale

C /\

(n =15)

ANOVA

Note: if- eta-squared measure of effect size. Means in the same row that do not share subscripts
differ significantly in the Tukey HSD comparison, *p < .05.
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